Holen Sie sich die Stockscreener-App
7.27
0.55%
0.04
Handel nachbörslich:
3.43
-3.84
-52.82%
Schlusskurs vom Vortag:
$7.23
Offen:
$7.28
24-Stunden-Volumen:
859.53K
Relative Volume:
1.13
Marktkapitalisierung:
$1.08B
Einnahmen:
$342.81M
Nettoeinkommen (Verlust:
$97.67M
KGV:
11.83
EPS:
0.6145
Netto-Cashflow:
$50.46M
1W Leistung:
+0.41%
1M Leistung:
+9.16%
6M Leistung:
-12.20%
1J Leistung:
+15.76%
1-Tages-Spanne:
$7.24
$7.45
1-Wochen-Bereich:
$6.89
$7.45
52-Wochen-Spanne:
$5.47
$10.14
Mimedx Group Inc Stock (MDXG) Company Profile
Firmenname
Mimedx Group Inc
Sektor
Branche
Telefon
(770) 651-9100
Adresse
1775 W OAK COMMONS COURT, NE, MARIETTA
Vergleichen Sie MDXG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| 6.49 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
0.90 | 1.23B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.38 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.60 | 112.82M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.1534 | 324.91M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.4425 | 0 | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-03-07 | Eingeleitet | Lake Street | Buy |
| 2023-10-27 | Eingeleitet | Craig Hallum | Buy |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-07-26 | Eingeleitet | Northland Capital | Outperform |
| 2021-03-19 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Mimedx Group Inc Aktie (MDXG) Neueste Nachrichten
US Ophthalmology Amniotic Membrane Market to Reach $7.35B - openPR.com
What makes MiMedx Group Inc. stock price move sharplyMulti-Fold Return Candidates - mustnews.co.kr
There May Be Reason For Hope In MiMedx Group's (NASDAQ:MDXG) Disappointing Earnings - Yahoo Finance
Clover Health and MiMedx Group Receive Bullish Analyst Sentiments - AInvest
Why MiMedx Group Inc. stock attracts strong analyst attentionShort Term High Yield Stock Tips for Active Traders - metal.it
Analysts Conflicted on These Healthcare Names: Moderna (MRNA) and MiMedx Group (MDXG) - The Globe and Mail
MiMedx Group Inc. Reports Record Earnings and Growth - TipRanks
MiMedx raises full-year revenue growth outlook to low double digits as momentum builds post-record quarter - MSN
Is MiMedx Group Inc. a good long term investmentFree Consultation - Jammu Links News
What drives MiMedx Group Inc. stock priceBuild wealth faster with consistent investment plans - Jammu Links News
Published on: 2025-08-04 04:52:32 - Jammu Links News
What are analysts’ price targets for MiMedx Group Inc. in the next 12 monthsHigh-yield investments - Jammu Links News
MiMedx Group Inc. Stock Analysis and ForecastCapitalize on stocks with high profit margins - Jammu Links News
When is MiMedx Group Inc. stock expected to show significant growthAchieve breakthrough financial results - Jammu Links News
Should I hold or sell MiMedx Group Inc. stock in 2025Consistently superior profits - Jammu Links News
What institutional investors are buying MiMedx Group Inc. stockCapitalize on high-yield stock opportunities - Jammu Links News
How does MiMedx Group Inc. generate profit in a changing economyHarness the power of proven investment plans - Jammu Links News
What catalysts could drive MiMedx Group Inc. stock higher in 2025Free Investment Community - Jammu Links News
What is the dividend policy of MiMedx Group Inc. stockAchieve fast wealth growth with smart picks - Jammu Links News
Is it the right time to buy MiMedx Group Inc. stockMaximize gains with data-driven stock picks - Jammu Links News
What are the latest earnings results for MiMedx Group Inc.Achieve explosive financial results today - Jammu Links News
What is the risk reward ratio of investing in MiMedx Group Inc. stockAchieve breakthrough results with expert guidance - Jammu Links News
MiMedx Exceeds Q2 Revenue Expectations with Double-Digit Growth, Achieving Highest Quarterly Net Sales to Date. - AInvest
MiMedx Q2 2025 Earnings: EPS of $0.06 Beats Estimates, Revenue Hits $99 Million Surpassing Projections - AInvest
MiMedx Group Anticipates Improved EBITDA Margin for FY25, Projects Low Double-Digit Annual Net Sales Growth - AInvest
MiMedx Group, Inc. (NASDAQ:MDXG) Q2 2025 Earnings Call Transcript - Insider Monkey
MiMedx Group Reports Record Q2 2025 Financial Results - The Globe and Mail
MiMedx Group Inc. Achieves Impressive Q2 Financial ResultsNews and Statistics - IndexBox
MiMedx Group 2025 Q2 Earnings Mixed Results with Net Income Down 45% - AInvest
MiMedx stock price target raised to $12 from $11 at Cantor Fitzgerald - Investing.com Australia
MiMedx Price Target Raised to $12 Amid Q2 Revenue Beat and 2025 Guidance Increase - AInvest
MiMedx Group Stock Soars 11.35% on Record Q2 Earnings - AInvest
MiMedx: Q2 Earnings Snapshot - Connecticut Post
Published on: 2025-07-31 13:51:17 - beatles.ru
MiMedx Group Inc (MDXG) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... - Yahoo Finance
MiMedx Group Inc (MDXG) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Growth ... By GuruFocus - Investing.com Canada
MiMedx Reports Record Q2 2025 Financial Results - TipRanks
MiMedx Raises Full-Year Revenue Growth Outlook to Low Double Digits, Posting Record Q2 Results - AInvest
MiMedx's Q2 2025 Earnings Call: Contradictions on Market Share, Regulations, and Growth Prospects - AInvest
MiMedx Partners With Vaporox To Expand Wound Care Portfolio And Invests In VHT Technology - Nasdaq
Earnings call transcript: MiMedx Q2 2025 beats earnings forecasts, stock rises - Investing.com
Earnings call transcript: MiMedx Q2 2025 beats earnings forecasts, stock rises By Investing.com - Investing.com Nigeria
Finanzdaten der Mimedx Group Inc-Aktie (MDXG)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):